EVE HOLDING INC (EVEX) Fundamental Analysis & Valuation

NYSE:EVEXUS29970N1046

Current stock price

2.86 USD
-0.01 (-0.35%)
At close:
2.86 USD
0 (0%)
After Hours:

This EVEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EVEX Profitability Analysis

1.1 Basic Checks

  • EVEX had negative earnings in the past year.
  • EVEX had a negative operating cash flow in the past year.
  • In the past 5 years EVEX always reported negative net income.
  • EVEX had a negative operating cash flow in each of the past 5 years.
EVEX Yearly Net Income VS EBIT VS OCF VS FCFEVEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M

1.2 Ratios

  • EVEX has a worse Return On Assets (-51.57%) than 90.00% of its industry peers.
  • With a Return On Equity value of -181.20%, EVEX is not doing good in the industry: 91.25% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -51.57%
ROE -181.2%
ROIC N/A
ROA(3y)-49.01%
ROA(5y)-61.27%
ROE(3y)-123.35%
ROE(5y)-110.37%
ROIC(3y)N/A
ROIC(5y)N/A
EVEX Yearly ROA, ROE, ROICEVEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

1.3 Margins

  • EVEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVEX Yearly Profit, Operating, Gross MarginsEVEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

3

2. EVEX Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for EVEX has been increased compared to 1 year ago.
  • EVEX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EVEX has been reduced compared to a year ago.
EVEX Yearly Shares OutstandingEVEX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
EVEX Yearly Total Debt VS Total AssetsEVEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of -1.28, we must say that EVEX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of EVEX (-1.28) is worse than 88.75% of its industry peers.
  • A Debt/Equity ratio of 1.43 is on the high side and indicates that EVEX has dependencies on debt financing.
  • The Debt to Equity ratio of EVEX (1.43) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z -1.28
ROIC/WACCN/A
WACCN/A
EVEX Yearly LT Debt VS Equity VS FCFEVEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 3.29 indicates that EVEX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.29, EVEX is in line with its industry, outperforming 58.75% of the companies in the same industry.
  • EVEX has a Quick Ratio of 3.29. This indicates that EVEX is financially healthy and has no problem in meeting its short term obligations.
  • EVEX's Quick ratio of 3.29 is fine compared to the rest of the industry. EVEX outperforms 78.75% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 3.29
EVEX Yearly Current Assets VS Current LiabilitesEVEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1

3. EVEX Growth Analysis

3.1 Past

  • The earnings per share for EVEX have decreased strongly by -44.38% in the last year.
EPS 1Y (TTM)-44.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, EVEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.17% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.72%
EPS Next 2Y1.18%
EPS Next 3Y10.52%
EPS Next 5Y11.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVEX Yearly Revenue VS EstimatesEVEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
EVEX Yearly EPS VS EstimatesEVEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 -0.2 0.4 -0.4 -0.6

0

4. EVEX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EVEX. In the last year negative earnings were reported.
  • Also next year EVEX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVEX Price Earnings VS Forward Price EarningsEVEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVEX Per share dataEVEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.18%
EPS Next 3Y10.52%

0

5. EVEX Dividend Analysis

5.1 Amount

  • No dividends for EVEX!.
Industry RankSector Rank
Dividend Yield 0%

EVEX Fundamentals: All Metrics, Ratios and Statistics

EVE HOLDING INC

NYSE:EVEX (4/28/2026, 8:27:41 PM)

After market: 2.86 0 (0%)

2.86

-0.01 (-0.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Industry Strength71.43
Industry Growth88.82
Earnings (Last)03-16
Earnings (Next)05-12
Inst Owners12.15%
Inst Owner Change-0.01%
Ins Owners0.29%
Ins Owner Change0%
Market Cap996.14M
Revenue(TTM)N/A
Net Income(TTM)-224.25M
Analysts78.67
Price Target7.17 (150.7%)
Short Float %7.52%
Short Ratio5.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.59%
Min EPS beat(2)-13.12%
Max EPS beat(2)16.31%
EPS beat(4)1
Avg EPS beat(4)-8.65%
Min EPS beat(4)-27.33%
Max EPS beat(4)16.31%
EPS beat(8)5
Avg EPS beat(8)4.01%
EPS beat(12)9
Avg EPS beat(12)9.2%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.05%
PT rev (3m)-2.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.81%
EPS NY rev (1m)-6.21%
EPS NY rev (3m)-11.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-76.64%
Revenue NY rev (3m)-78.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.05
P/tB 8.05
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS0
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -51.57%
ROE -181.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-49.01%
ROA(5y)-61.27%
ROE(3y)-123.35%
ROE(5y)-110.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1584.41%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 3.29
Altman-Z -1.28
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1233.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-0.72%
EPS Next 2Y1.18%
EPS Next 3Y10.52%
EPS Next 5Y11.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.63%
EBIT Next 3Y12.72%
EBIT Next 5Y31.02%
FCF growth 1Y-24.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18%
OCF growth 3YN/A
OCF growth 5YN/A

EVE HOLDING INC / EVEX Fundamental Analysis FAQ

What is the fundamental rating for EVEX stock?

ChartMill assigns a fundamental rating of 1 / 10 to EVEX.


What is the valuation status for EVEX stock?

ChartMill assigns a valuation rating of 0 / 10 to EVE HOLDING INC (EVEX). This can be considered as Overvalued.


What is the profitability of EVEX stock?

EVE HOLDING INC (EVEX) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for EVEX stock?

The Earnings per Share (EPS) of EVE HOLDING INC (EVEX) is expected to decline by -0.72% in the next year.